420 related articles for article (PubMed ID: 20224070)
41. A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-κB inhibition.
Kobayashi Y; Wada H; Rossios C; Takagi D; Higaki M; Mikura S; Goto H; Barnes PJ; Ito K
J Pharmacol Exp Ther; 2013 Apr; 345(1):76-84. PubMed ID: 23359665
[TBL] [Abstract][Full Text] [Related]
42. Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease.
Jiang Z; Zhu L
Pulm Pharmacol Ther; 2016 Apr; 37():1-8. PubMed ID: 26805715
[TBL] [Abstract][Full Text] [Related]
43. Histone deacetylation: an important mechanism in inflammatory lung diseases.
Adcock IM; Ito K; Barnes PJ
COPD; 2005 Dec; 2(4):445-55. PubMed ID: 17147010
[TBL] [Abstract][Full Text] [Related]
44. Lung inflammation changes and oxidative stress induced by cigarette smoke exposure in guinea pigs affected by Zataria multiflora and its constituent, carvacrol.
Boskabady MH; Gholami Mahtaj L
BMC Complement Altern Med; 2015 Mar; 15():39. PubMed ID: 25881210
[TBL] [Abstract][Full Text] [Related]
45. Passive smoking impairs histone deacetylase-2 in children with severe asthma.
Kobayashi Y; Bossley C; Gupta A; Akashi K; Tsartsali L; Mercado N; Barnes PJ; Bush A; Ito K
Chest; 2014 Feb; 145(2):305-312. PubMed ID: 24030221
[TBL] [Abstract][Full Text] [Related]
46. Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD.
Chen YH; Yao WZ; Ding YL; Geng B; Lu M; Tang CS
Pulm Pharmacol Ther; 2008; 21(1):40-6. PubMed ID: 17196413
[TBL] [Abstract][Full Text] [Related]
47. [Theophylline, a new look to an old drug].
Morfín Maciel BM; Castillo Morfín BM
Rev Alerg Mex; 2010; 57(4):112-22. PubMed ID: 21255523
[TBL] [Abstract][Full Text] [Related]
48. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.
Cosio BG; Tsaprouni L; Ito K; Jazrawi E; Adcock IM; Barnes PJ
J Exp Med; 2004 Sep; 200(5):689-95. PubMed ID: 15337792
[TBL] [Abstract][Full Text] [Related]
49. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
50. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
Knobloch J; Wahl C; Feldmann M; Jungck D; Strauch J; Stoelben E; Koch A
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):202-9. PubMed ID: 23981542
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoid resistance in inflammatory diseases.
Barnes PJ; Adcock IM
Lancet; 2009 May; 373(9678):1905-17. PubMed ID: 19482216
[TBL] [Abstract][Full Text] [Related]
52. Selective role of PI3K delta in neutrophil inflammatory responses.
Sadhu C; Dick K; Tino WT; Staunton DE
Biochem Biophys Res Commun; 2003 Sep; 308(4):764-9. PubMed ID: 12927784
[TBL] [Abstract][Full Text] [Related]
53. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease.
Milara J; Díaz-Platas L; Contreras S; Ribera P; Roger I; Ballester B; Montero P; Cogolludo Á; Morcillo E; Cortijo J
Respir Res; 2018 Nov; 19(1):226. PubMed ID: 30458870
[TBL] [Abstract][Full Text] [Related]
54. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
Tamimi A; Serdarevic D; Hanania NA
Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
[TBL] [Abstract][Full Text] [Related]
55. The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle.
Ge Q; Moir LM; Trian T; Niimi K; Poniris M; Shepherd PR; Black JL; Oliver BG; Burgess JK
J Cell Physiol; 2012 Aug; 227(8):3044-52. PubMed ID: 22015454
[TBL] [Abstract][Full Text] [Related]
56. Corticosteroids: the drugs to beat.
Barnes PJ
Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
[TBL] [Abstract][Full Text] [Related]
57. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline.
Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M
Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764
[TBL] [Abstract][Full Text] [Related]
58. Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy.
Marwick JA; Ito K; Adcock IM; Kirkham PA
Expert Opin Ther Targets; 2007 Jun; 11(6):745-55. PubMed ID: 17504013
[TBL] [Abstract][Full Text] [Related]
59. Phosphoinositide 3-kinase-δ regulates fungus-induced allergic lung inflammation through endoplasmic reticulum stress.
Lee KS; Jeong JS; Kim SR; Cho SH; Kolliputi N; Ko YH; Lee KB; Park SC; Park HJ; Lee YC
Thorax; 2016 Jan; 71(1):52-63. PubMed ID: 26543090
[TBL] [Abstract][Full Text] [Related]
60. Role of HDAC2 in the pathophysiology of COPD.
Barnes PJ
Annu Rev Physiol; 2009; 71():451-64. PubMed ID: 18817512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
